Ahead of Sitagliptin going off-Patent, NPPA moves to fix retail price of its FDC Meghna Singhania Meghna A Singhania15 April 2022 11:52 AM GMTNew Delhi: With the popular antidiabetic drug Sitagliptin soon expected to go off-patent, the apex drug price regulator, National Pharmaceutical...
Kilitch Drugs starts Rs. 100 crore New Facility Expansion Plan MD Bureau22 March 2022 10:58 AM GMTMukund Mehta, Chairman & Managing Director of Kilitch Drugs, said, "We are on a growth trajectory and demand for our products is increasing. This...
Mankind Pharma gets CDSCO panel nod for trial of anti diabetic molecule, MKP10241 Medical Dialogues Team20 Jun 2021 4:30 AM GMTNew Delhi: Approving the Investigational New Drug (IND) application for Novel Anti Diabetic Molecule, MKP10241, the Subject Expert Committee (SEC) of...
